168 related articles for article (PubMed ID: 35111662)
1. Lipid Changes During Endocrine Therapy in Breast Cancer Patients: The Results of a 5-Year Real-World Retrospective Analysis.
He T; Li X; Li J; Wang Z; Fan Y; Li X; Fu Z; Wu Y; Lv Q; Luo T; Zhong X; Chen J
Front Oncol; 2021; 11():670897. PubMed ID: 35111662
[TBL] [Abstract][Full Text] [Related]
2. Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study.
Li Y; Deng Z; Wang Y; Shen S
Lipids Health Dis; 2024 Jan; 23(1):9. PubMed ID: 38191454
[TBL] [Abstract][Full Text] [Related]
3. The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.
Hozumi Y; Suemasu K; Takei H; Aihara T; Takehara M; Saito T; Ohsumi S; Masuda N; Ohashi Y
Ann Oncol; 2011 Aug; 22(8):1777-82. PubMed ID: 21285133
[TBL] [Abstract][Full Text] [Related]
4. The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.
Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Cufer T; Lobelle JP; Mattiaci MR; Piccart M; Paridaens R
Ann Oncol; 2004 Feb; 15(2):211-7. PubMed ID: 14760111
[TBL] [Abstract][Full Text] [Related]
5. Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies.
Wang K; Shen L; Tian W; Zhang S
Sci Rep; 2022 Dec; 12(1):22650. PubMed ID: 36587111
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy-associated lipid changes in breast cancer patients: A real-word retrospective analysis.
He T; Wang C; Tan Q; Wang Z; Li J; Chen T; Cui K; Wu Y; Sun J; Zheng D; Lv Q; Chen J
Medicine (Baltimore); 2020 Aug; 99(33):e21498. PubMed ID: 32871996
[TBL] [Abstract][Full Text] [Related]
7. Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer.
Kusama M; Miyauchi K; Aoyama H; Sano M; Kimura M; Mitsuyama S; Komaki K; Doihara H
Breast Cancer Res Treat; 2004 Nov; 88(1):1-8. PubMed ID: 15538040
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dyslipidemia incidence in Chinese early-stage breast cancer patients following different endocrine therapies: A population-based cohort study.
Wang J; Yin J; Qiu J; Jiang J; Hu Y; Zhu K; Zheng H; Luo T; Zhong X
Front Endocrinol (Lausanne); 2022; 13():815960. PubMed ID: 36147563
[TBL] [Abstract][Full Text] [Related]
9. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
[TBL] [Abstract][Full Text] [Related]
10. Could Anthropometric and Lipid Parameters Reflect Susceptibility to Breast Cancer? Comparison of Newly Diagnosed Breast Cancer and Apparently Healthy Women.
Akalanka HMK; Ekanayake S; Samarasinghe K
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2475-2480. PubMed ID: 30255702
[TBL] [Abstract][Full Text] [Related]
11. Lipid changes during the perioperative period in patients with early breast cancer: a real-world retrospective analysis.
He T; Wang Z; Wu Y; Zhang X; Li X; Li J; Du L; Chen J; Lv Q
BMC Surg; 2021 Nov; 21(1):396. PubMed ID: 34772381
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer.
Gil JM; Rubio-Terrés C; Del Castillo A; González P; Canorea F
Clin Transl Oncol; 2006 May; 8(5):339-48. PubMed ID: 16760009
[TBL] [Abstract][Full Text] [Related]
13. The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).
Wasan KM; Goss PE; Pritchard PH; Shepherd L; Palmer MJ; Liu S; Tu D; Ingle JN; Heath M; Deangelis D; Perez EA
Ann Oncol; 2005 May; 16(5):707-15. PubMed ID: 15817595
[TBL] [Abstract][Full Text] [Related]
14. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
[TBL] [Abstract][Full Text] [Related]
15. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
[TBL] [Abstract][Full Text] [Related]
16. Crossover trial for lipid abnormality in postmenopausal breast cancer patients during selective estrogen receptor modulators (SERMs) administrations.
Kusama M; Kaise H; Nakayama S; Ota D; Misaka T; Aoki T
Breast Cancer Res Treat; 2004 Nov; 88(1):9-16. PubMed ID: 15538041
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer.
Li L; Chang B; Jiang X; Fan X; Li Y; Li T; Wu S; Zhang J; Kariminia S; Li Q
BMC Cancer; 2018 Oct; 18(1):977. PubMed ID: 30314452
[TBL] [Abstract][Full Text] [Related]
18. Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study.
Shien T; Doihara H; Sato N; Anan K; Komaki K; Miyauchi K; Yanagita Y; Fujisawa T; Mitsuyama S; Kanbayashi C; Kusama M; Kimura M; Jinno H; Sano M; Ikeda T
Cancer Chemother Pharmacol; 2018 Feb; 81(2):269-275. PubMed ID: 29196963
[TBL] [Abstract][Full Text] [Related]
19. Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.
Anan K; Mitsuyama S; Yanagita Y; Kimura M; Doihara H; Komaki K; Kusama M; Ikeda T
Breast Cancer Res Treat; 2011 Aug; 128(3):775-81. PubMed ID: 21638048
[TBL] [Abstract][Full Text] [Related]
20. [Effects of anastrozole on lipid metabolism in Chinese postmenopausal women with breast cancer].
Lu HH; Li Q; Xu BH; Zhang P; Yuan P; Wang JY; Cai RG
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):520-5. PubMed ID: 22093630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
